Linkage between retinoid and fatty acid receptors: Implications for breast cancer prevention

European Journal of Cancer Prevention

Volumn 11, Issue 4, 2002, Pages 319-325

  Stoll, B A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Fatty acids; Fenretinide; PPAR gamma; PUFA; RAR; Retinoids; RXR; Thiazolidinediones; Troglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FATTY ACID; FENRETINIDE; ICOSANOID; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOID; RETINOID X RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TROGLITAZONE;

ANIMAL TISSUE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CELL NUCLEUS; CELL STRUCTURE; CHEMOPROPHYLAXIS; DRUG RECEPTOR BINDING; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; ORGAN CULTURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; INSULIN RESISTANCE; MAMMARY NEOPLASMS, ANIMAL; MICE; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0036684409     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200208000-00002     Document Type: Review

References (64)

1. Rising global burden of diabetes and its complications
2. RAR and RXR in ductal carcinoma in situ and intraductal proliferative lesions of the human breast
3. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers
4. Retinoid mechanisms and cyclins
5. Fat, fish oil and cancer
6. Polyunsaturated fatty acid regulation of gene transcription: A mechanism to improve energy balance and insulin resistance
7. Type 1 IGF receptor gene expression in normal human breast tissue treated with oestrogen and progesterone
8. Influence of J-series prostaglandins on apoptosis and tumorigenesis of breast cancer cells
9. Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer
10. Role of antioxidants and intracellular free radicals in retinamide-induced cell death
11. A phase II chemoprevention trial design to identify surrogate and biomarkers in breast cancer
12. Ligands for PPAR gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
13. Epigenetic lesions causing genetic lesions in human cancer: Promoter hypermethylation of DNA repair genes
14. Retinoids: Present role and future potential
15. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation
16. Apoptosis induction and potent antiestrogen receptor negative breast cancer activity in vivo by a retinoid antagonist
17. Expression of PPAR mRNA in normal and tumorigenic rodent mammary glands
18. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma
19. Elevated expression of RAR alpha in ER positive breast carcinoma by immunohistochemistry
20. Dietary factors and risk of breast cancer: Combined analysis of 12 case-control studies
21. Types of dietary fat and incidence of cancer at five sites
22. The PPAR: RXR heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
23. DNA methylation analysis at distal and proximal promoter regions of the ER gene in breast cancers
24. Estrogen receptor beta is co-expressed with ER alpha and PR, and associated with nodal status, grade and proliferation rate in breast cancer
25. Defective expression of CRBP 1 and RAR alpha 2, beta 2 and gamma 2 in human breast cancer cells
26. Regulation of gene expression by dietary fat
27. Fish consumption and breast cancer risk: Ecological study
28. Signaling cross-talk between PPAR/RXR and estrogen receptor through estrogen response elements
29. Roles of PPARs in health and disease
30. Fatty acids and eicosanoids regulate gene expression through direct interactions with PPAR alpha and gamma
31. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients
32. Cellular retinol-binding protein expression and breast cancer
33. Altered oestrogen receptor alpha and beta mRNA expression during human breast tumorigenesis
34. A ligand of PPAR gamma, retinoids, and prevention of preneoplastic mammary lesions
35. Terminal differentiation of human breast cancer through PPAR gamma
36. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
37. Retinoic acid: Its biosynthesis and metabolism
38. Ectopic expression of cyclin D amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells
39. Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA
40. RXR and PPAR activate an estrogen responsive gene independent of the oestrogen receptor
41. Effects of dietary n-3 fatty acids on human breast cancer growth and metastasis to lung in nude mice
42. PPAR gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue. Possible implications for breast cancer therapy
43. Effect of all-transretinoic acid on CSF-1 receptor expression and CSF-1 induced invasion and anchorage independent growth of human breast carcinoma cells
44. Oestrogen receptor expression in the normal and precancerous breast
45. Cell cyclin D1 is associated with ER but not Ki67 in normal, precancerous and cancerous breast lesions
46. Novel translational model for breast cancer chemoprevention: Accrual to a presurgical intervention with tamoxifen and N (4 hydroxyphenyl) retihamide
47. Cyclins and breast cancer
48. Loss of growth-inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid
49. Biological mechanisms in breast cancer invasiveness: Relevance to preventative interventions
50. A new ligand for PPAR gamma, GW7845, inhibits rat mammary carcinogenesis
51. Regulation of vitamin A metabolism-related gene expression
52. Effects of all-transretinoic acid and 13-cis-retinoic acid on breast cancer cells growth inhibition and apoptosis induction
53. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis
54. Immunohistochemical analysis of RAR alpha in human breast tumours: RAR alpha expression correlates with proliferative activity
55. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
56. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast
57. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer
58. Progressive decrease in nuclear RAR beta messenger RNA level during breast carcinogenesis
59. Discrete roles for PPAR gamma and RXR in recruiting nuclear receptor coactivators
60. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer
61. Distinct mechanisms of loss of ER alpha gene expression in human breast cancer: Methylation of the gene and alteration of transacting factors
62. Dietary carotenoids and vitamins A, C and E and risk of breast cancer
63. Retinoid receptors in human lung and breast cancers
64. Linoleic acid intake and cancer risk: A review and meta-analysis